Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 15;70(2):29-35.
doi: 10.15585/mmwr.mm7002a1.

Cancer Screening Test Receipt - United States, 2018

Cancer Screening Test Receipt - United States, 2018

Susan A Sabatino et al. MMWR Morb Mortal Wkly Rep. .

Abstract

Screening for breast cancer, cervical cancer, and colorectal cancer (CRC) reduces mortality from these cancers.* However, screening test receipt has been below national targets with disparities observed in certain populations (1,2). National Health Interview Survey (NHIS) data from 2018 were analyzed to estimate percentages of adults up to date with U.S. Preventive Services Task Force (USPSTF) screening recommendations. Screening test receipt remained below national Healthy People 2020 (HP2020) targets, although CRC test receipt neared the target. Disparities were evident, with particularly low test receipt among persons who were uninsured or did not have usual sources of care. Continued monitoring helps assess progress toward targets and could inform efforts to promote screening and reduce barriers for underserved populations.

PubMed Disclaimer

Conflict of interest statement

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

Figures

FIGURE
FIGURE
Percentage of adults up to date with screening for breast, cervical, and colorectal cancers, by cancer type, sex, and year — United States, 2005–2018 * Up to date with U.S. Preventive Services Task Force screening recommendations in effect for each year defined as breast cancer: mammography within 2 years among women aged 50–74 years (all survey years); cervical cancer 2015–2018: Pap test within 3 years among women aged 21–65 years without hysterectomy, or Pap test plus human papillomavirus (HPV) test (co-testing) within 5 years among women aged 30–65 years without hysterectomy; cervical cancer before 2015: Pap test within 3 years among women aged 21–65 years without hysterectomy; colorectal cancer (CRC) 2018: home blood stool test within 1 year, sigmoidoscopy or computed tomography (CT) colonography within 5 years, colonoscopy within 10 years, or fecal immunochemical test (FIT)–DNA test within 3 years among adults aged 50–75 years; CRC 2010–2015: home blood stool test within 1 year, colonoscopy within 10 years, or sigmoidoscopy within 5 years with home blood stool test within 3 years among adults aged 50–75 years; CRC 2005–2008: home blood stool test within 1 year, colonoscopy within 10 years, or sigmoidoscopy within 5 years among adults aged 50–75 years.

Similar articles

Cited by

References

    1. White A, Thompson TD, White MC, et al. Cancer screening test use—United States, 2015. MMWR Morb Mortal Wkly Rep 2017;66:201–6. 10.15585/mmwr.mm6608a1 - DOI - PMC - PubMed
    1. Sabatino SA, White MC, Thompson TD, Klabunde CN; CDC. Cancer screening test use—United States, 2013. MMWR Morb Mortal Wkly Rep 2015;64:464–8. - PMC - PubMed
    1. CDC. National Health Interview Survey: survey description. Hyattsville, MD: US Department of Health and Human Services, CDC, National Center for Health Statistics; 2019. ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NHIS/....
    1. Parker JD, Talih M, Malec DJ, et al. National Center for Health Statistics data presentation standards for proportions. Vital Health Stat 2 2017;2:1–22. - PubMed
    1. Shapiro JA, Klabunde CN, Thompson TD, Nadel MR, Seeff LC, White A. Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 2012;21:895–904. 10.1158/1055-9965.EPI-12-0192 - DOI - PMC - PubMed